Posted by Michael Wonder on 27 Jul 2016
TGA finally approves Latisse (bimatoprost)
27 July 2016 - The TGA has approved a new use for Allergan's bimatoprost.
The TGA approved bimatoprost (Latisse) on 14 July 2016 to treat hypotrichosis of the eye lashes in adults by increasing their growth including, but not necessarily all of, length, thickness and darkness.
The TGA rejected the inital application in April 2014.
